Connell Consulting
Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.

Posted on: 26/09/2011

Latest news stories

Nuffield Health has announced that Steve Gray will replace David Mobbs as chief executive.
Priory Group has acquired Life Works, a private behavioural care clinic in Old Woking, Surrey from Glenholme Healthcare Group.
Healthcare software company Orion Health has signed a contract with Boots UK to roll out its technology in all 2,400 Boots stores in the UK and Ireland.
Private equity house Bridgepoint Capital is in talks to purchase the UK's biggest retirement homes developer McCarthy & Stone, according to Sky News.
Washington DC-based private equity firm Halifax Group has sold Caring Brands International, a franchisor of home care services, for an undisclosed sum.

Proton Partners International wants to shake up the UK cancer care landscape by becoming the first provider to offer proton beam therapy on home soil. Ploy Radford talks to the firm’s chief executive, Mike Moran, to find out more

The dentistry markets in some European countries are ripe for consolidation finds Sunniva Davies-Rommetveit. But how do they compare to the UK?
Chancellor George Osborne dropped a bombshell on the care sector when he introduced the living wage in his summer budget. Kirsten Noben reports

Christie + Co
Central London Community Healthcare NHS Trust (CLCH) awarded Capita an £80 million, 10-year, back office contract in May this year. HealthInvestor talks to CLCH corporate services transformation director Phil Hall about the deal
Start-up Path has spotted a gap in the mobility market and could just better millions of lives as a result
HealthInvestor Awards judge Ian Wootton makes the case for a vibrant public private partnerships market.
Clare Connell and Hannah Hurley of Connell Consulting explore how efficiencies in local authorities’ own departments could help fund national living wage
Synova Capital’s management buyout of 4Ways has highlighted the attractive market trends in the UK teleradiology space

Click here to search all feature articles